Utility of Synovial Fluid Biomarkers for Culture-Positive Septic Arthritis in a Lyme Disease-Endemic Region

Andzelika Dechnik1, Caroline G Kahane2, Lise E Nigrovic2

  • 1From the Division of Pediatric Emergency Medicine, Department of Emergency Medicine, Columbia University, New York, NY.

PubMed

Insights

Synovial fluid biomarkers alone are insufficient for diagnosing septic arthritis in children. New diagnostic approaches are needed to accurately identify this serious joint infection in pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Orthopedic surgery
  • Diagnostic marker research

Background:

  • Septic arthritis is a serious joint infection in children requiring prompt diagnosis and treatment.
  • Accurate identification of septic arthritis is crucial to prevent long-term joint damage.
  • Current diagnostic methods rely on synovial fluid analysis, but their performance varies.

Purpose of the Study:

  • To assess the diagnostic performance of commonly used synovial fluid biomarkers for identifying culture-positive septic arthritis in children.
  • To determine the sensitivity and specificity of various synovial fluid markers.
  • To evaluate if any single biomarker is sufficient for diagnosing pediatric septic arthritis.

Main Methods:

  • Retrospective analysis of 796 children (6 months to 18 years) evaluated for septic arthritis.
  • Synovial fluid cultures were obtained to confirm septic arthritis.
  • Area under the receiver operating characteristic curve (AUC) analyses were used to evaluate biomarker performance.

Main Results:

  • Of 796 children, 79 (10%) had septic arthritis.
  • Synovial fluid glucose (AUC, 0.78) and white blood cell count (AUC, 0.72) showed moderate diagnostic accuracy.
  • Protein (AUC, 0.52) had low diagnostic accuracy; a positive Gram stain was highly specific (99.1%) but had low sensitivity (48.1%).

Conclusions:

  • No single routinely available synovial fluid biomarker demonstrated sufficient accuracy for isolated use in diagnosing pediatric septic arthritis.
  • Current biomarkers have limitations in accurately identifying septic arthritis in children.
  • Development of multivariate clinical prediction rules and novel biomarkers is necessary for improved diagnosis.
Abstract